Clearwater weighing options after failures at mill acquired from Graphic Packaging GPK Packaging Dive ...

TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and ADNOC Gas announced today a five-year liquefied natural gas (LNG) supply agreement, under which ADNOC Gas will supply a total of up to 1.6 million ...

Coca-Cola Europacific Partners (NASDAQ:CCEP) reported stronger-than-expected third-quarter trading, supported by higher beverage volumes and revenue growth across its European and Asia Pacific ...

Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the ...

Teva to obtain U.S. commercialization rights for two immunology biosimilars: ETICOVO ® upon close and infliximab-abda in Q3 2027; Collaboration combines Samsung Bioepis’ biosim ...

Apple (NASDAQ:AAPL) and Palantir Technologies (NASDAQ:PLTR) both declined in after-hours trading despite reporting quarterly results that exceeded analysts’ expectations. Apple’s weaker gross margin ...

(NYSE: KTB) today announced it has completed the sale of the Lee ® business to Authentic Brands Group. "I want to thank the Kontoor team for the tremendous effort that drove the successful completion ...

The financial results for 2025 differ from the preliminary unaudited results disclosed in the Company's November 4, 2025 earnings press release. The changes primarily relate to the finalization of ...

Q3 gross profit increased 37% year-over-year to a record $98.7 million, driven by strong marketplace growth. Record Q3 marketplace gross margin of 36.0%, an increase of 30 bps year-over-year. Q3 ...

Citing people familiar with the discussions, Bloomberg reported that Disney has asked certain managers to identify opportunities to achieve annual cost savings of 20%. The proposed measures come as ...

November 3, 2026) - Elemental Royalty Corporation (NASDAQ: ELE) (TSX: ELE) (" Elemental ") will release its Q3 2026 results after market close on Tuesday, November 10, 2026. An investor webcast will ...

Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced it will report its third quarter 2026 financial results ...